FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045196281> ?p ?o ?g. }

• W3045196281 endingPage "e21270" @default.
• W3045196281 startingPage "e21270" @default.
• W3045196281 abstract "Abstract In a hepatitis C virus (HCV)/HIV-positive Brazilian cohort, evaluate the safety and efficacy of HCV DAAs, the frequency of resistance substitutions in the HCV NS5A and NS5B genes and identify predictors of treatment failure. Retrospective multicenter study of HCV/HIV patients treated with sofosbuvir (SOF)-based regimens at 10 reference centers in Brazil. Clinical and virological data were collected. Genetic diversity in the NS5A and NS5B genes was assessed by direct nucleotide sequencing. The primary outcome was sustained virological response (SVR) 12 weeks after DAA completion. Of 643 HCV/HIV patients analyzed, 74.7% were male, median CD4+ T cell count was 617 cells/mm 3 , 90% had an undetectable HIV viral load. HCV genotype 1 was detected in 80.2%, and 60% were taking at least 1 medication other than antiretroviral drugs during their DAA therapy. Cirrhosis was present in 42%. An SOF/daclatasvir (DCV) regimen was used in most patients (98%). The frequency of NS5A polymorphisms associated with clinically relevant resistance to DCV was 2%; no relevant NS5B variants were identified. The SVR12 rate was 92.8% in an intention to treat (ITT) analysis and 96% in a modified ITT (m-ITT) analysis. AE occurred in 1.6% of patients. By multivariate analysis, therapeutic failure was associated, in the m-ITT analysis, with concomitant use of anticonvulsant drugs ( P = .001), age ( P = .04), and female gender ( P = .04). SOF/DCV regimens were associated with a high SVR rate in an HCV/HIV population. The use of concurrent anticonvulsant drugs and DAAs decreases the chances of achieving an SVR." @default.
• W3045196281 created "2020-07-29" @default.
• W3045196281 creator A5004848036 @default.
• W3045196281 creator A5007641399 @default.
• W3045196281 creator A5011362289 @default.
• W3045196281 creator A5012711683 @default.
• W3045196281 creator A5023245595 @default.
• W3045196281 creator A5024025115 @default.
• W3045196281 creator A5026995321 @default.
• W3045196281 creator A5032228584 @default.
• W3045196281 creator A5035587984 @default.
• W3045196281 creator A5038212007 @default.
• W3045196281 creator A5038527623 @default.
• W3045196281 creator A5039102696 @default.
• W3045196281 creator A5053561529 @default.
• W3045196281 creator A5055608441 @default.
• W3045196281 creator A5056508802 @default.
• W3045196281 creator A5073083599 @default.
• W3045196281 creator A5073121486 @default.
• W3045196281 creator A5083213041 @default.
• W3045196281 date "2020-07-24" @default.
• W3045196281 modified "2023-09-30" @default.
• W3045196281 title "Effectiveness of direct-acting antivirals for hepatitis C virus infection in hepatitis C/HIV coinfected individuals" @default.
• W3045196281 cites W1826210767 @default.
• W3045196281 cites W1971991764 @default.
• W3045196281 cites W1976619831 @default.
• W3045196281 cites W2003780225 @default.
• W3045196281 cites W2027498662 @default.
• W3045196281 cites W2027545702 @default.
• W3045196281 cites W2035804055 @default.
• W3045196281 cites W2051126700 @default.
• W3045196281 cites W2059144654 @default.
• W3045196281 cites W2062563125 @default.
• W3045196281 cites W2063181418 @default.
• W3045196281 cites W2064387090 @default.
• W3045196281 cites W2075790861 @default.
• W3045196281 cites W2080175347 @default.
• W3045196281 cites W2092784580 @default.
• W3045196281 cites W2094174828 @default.
• W3045196281 cites W2097405564 @default.
• W3045196281 cites W2124892937 @default.
• W3045196281 cites W2148402252 @default.
• W3045196281 cites W2282504480 @default.
• W3045196281 cites W2287453238 @default.
• W3045196281 cites W2294421604 @default.
• W3045196281 cites W2314685793 @default.
• W3045196281 cites W2322431879 @default.
• W3045196281 cites W2325520215 @default.
• W3045196281 cites W2334367289 @default.
• W3045196281 cites W2394500959 @default.
• W3045196281 cites W2397427953 @default.
• W3045196281 cites W2418539241 @default.
• W3045196281 cites W2440842077 @default.
• W3045196281 cites W2460814285 @default.
• W3045196281 cites W2463047269 @default.
• W3045196281 cites W2473447033 @default.
• W3045196281 cites W2485759496 @default.
• W3045196281 cites W2521965558 @default.
• W3045196281 cites W2549090166 @default.
• W3045196281 cites W2588278672 @default.
• W3045196281 cites W2591108500 @default.
• W3045196281 cites W2594023123 @default.
• W3045196281 cites W2606093798 @default.
• W3045196281 cites W2622058694 @default.
• W3045196281 cites W2738454474 @default.
• W3045196281 cites W2748091751 @default.
• W3045196281 cites W2760952044 @default.
• W3045196281 cites W2767481642 @default.
• W3045196281 cites W2767749078 @default.
• W3045196281 cites W2769528747 @default.
• W3045196281 cites W2773476353 @default.
• W3045196281 cites W2773860847 @default.
• W3045196281 cites W2789691427 @default.
• W3045196281 cites W2789945358 @default.
• W3045196281 cites W2790614827 @default.
• W3045196281 cites W2866942771 @default.
• W3045196281 cites W2891874109 @default.
• W3045196281 cites W2943937662 @default.
• W3045196281 cites W2980366805 @default.
• W3045196281 cites W4211243282 @default.
• W3045196281 doi "https://doi.org/10.1097/md.0000000000021270" @default.
• W3045196281 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7387014" @default.
• W3045196281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32791706" @default.
• W3045196281 hasPublicationYear "2020" @default.
• W3045196281 type Work @default.
• W3045196281 sameAs 3045196281 @default.
• W3045196281 citedByCount "5" @default.
• W3045196281 countsByYear W30451962812021 @default.
• W3045196281 countsByYear W30451962812022 @default.
• W3045196281 countsByYear W30451962812023 @default.
• W3045196281 crossrefType "journal-article" @default.
• W3045196281 hasAuthorship W3045196281A5004848036 @default.
• W3045196281 hasAuthorship W3045196281A5007641399 @default.
• W3045196281 hasAuthorship W3045196281A5011362289 @default.
• W3045196281 hasAuthorship W3045196281A5012711683 @default.
• W3045196281 hasAuthorship W3045196281A5023245595 @default.
• W3045196281 hasAuthorship W3045196281A5024025115 @default.
• W3045196281 hasAuthorship W3045196281A5026995321 @default.

• next